News|Articles|February 20, 2026
Ethical Review & AI in Clinical Trials
Author(s)WCG
Discussion of opportunities on the ethical and regulatory challenges regarding artificial intelligence in clinical trials. The episode is focused through the lens of the IRB review, and how a multi-stakeholder task force led by the Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women’s Hospital and WCG will address the growing need for guidance in this rapidly evolving area of research.
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: Organizational Barriers to Programmatic Recruitment, Scaling Selective Safety Data Collection, and Subcutaneous Alzheimer's Treatment
2
FDA Finalizes Guidance on Clinical Trial Design for Psychedelic Drug Development
3
ACT Brief: Portfolio-Level Recruitment Strategy, Real-Time Burden Sampling, and Platinum-Free Bladder Cancer Therapy
4
Selective Safety Data Collection and the Case for Simpler Trials: Q&A with Rob DiCicco, TransCelerate Biopharma
5